ATS 2024 Final Program

Click on the session title to view the speakers

318

WEDNESDAY • MAY 22

10:03 Development and External Validation of a Machine Learning Model to Predict High Flow Nasal Cannula Failure

10:03 Using Causal Discovery Methods to Identify Predictors for Incident Lung Function Decline in COPD

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

D15 MACHINE LEARNING AND LARGE

D16 GENETICS AND BRONCHIECTASIS - ADVANCES IN CYSTIC FIBROSIS AND PRIMARY CILIARY DYSKINESIA 8:15 a.m. - 10:15 a.m. San Diego Convention Center Room 6A (Upper Level) Oral Presentations: 8:15 Fetal Risk Assessment for Cystic Fibrosis Via Fetal Cell Free DNA; A Non-invasive Pathway to Identify Fetuses Eligible for CFTR Modulator Therapy 8:27 The Role of Microtubule Stabilization in Bacterial Adherence and Internalization in Cystic Fibrosis 8:39 Racial and Ethnic Differences in Elexacaftor/Tezacaftor/Ivacaftor Provider Prescriptions for Variant-eligible People With Cystic Fibrosis 8:51 The Association Between Socioeconomic Status and In-hospital Healthcare Utilization and Cost Among Children With Cystic Fibrosis 9:03 Salivary Microarray Gene Expression of Pro-inflammatory Cytokines in Patients With Primary Ciliary Dyskinesia (PCD) 9:15 Radiant Cilia: Advancing North American Primary Ciliary Dyskinesia (PCD) Diagnostics With Immunofluorescence 9:27 Comparative Analysis of Clinical and Genetic Characteristics in Mexican Patients With Primary Ciliary Dyskinesia (PCD) Vs. Worldwide Trends 9:39 The Impact of Nutritional Status on Clinical Trajectories in Pediatric Patients With Primary Ciliary Dyskinesia 9:51 Predictors of Long-term Lung Function Trajectory in Primary Ciliary Dyskinesia Featured Speaker Presentation: 10:03 Precision Medicine in Pediatric Bronchiectasis: Forging a Path Towards Equitable Outcomes

COHORT STUDIES TO UNDERSTAND EXPOSURE-RELATED LUNG DISEASE

8:15 a.m. - 10:15 a.m.

San Diego Convention Center Room 28A-B (Upper Level)

Oral Presentations: 8:15 Indoor Air Pollution, Dysanapsis, and Lung Function Decline: Analyses From the SPIROMICS AIR Study 8:27 Mind the Height-gap: Association of a Novel Index of Growth Impairment With Airflow Obstruction in Adulthood 8:39 Environmental Urinary Cadmium Levels and Longitudinal Lung Function in the Multi-ethnic Study of Atherosclerosis 8:51 Associations Between Ambient PM2.5 Exposure, Plant-based Diet and Asthma Exacerbations: Analysis of the Nurses’ Health Studies 9:03 Comparable Radiographic Profiles of Suspected and Confirmed Deployment Related Respiratory Disease as Assessed by Parametric Response Mapping 9:15 Longitudinal Progression of CT Emphysema Subtypes Using Density-based and Hidden Markov Measure Field-based Thresholds: The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) 9:27 Overcoming Racial and Ethnic Biases in the Diagnosis of Patients With Alpha-1 Antitrypsin Deficiency in the United States Using a Machine-learning Model 9:39 Discovering Joint Clinical and Molecular Subtypes of COPD With Variational Autoencoders 9:51 Severity of COVID-19 Is Associated With Air Pollution: A Single Center Machine Learning Approach to Understand Risk

ATS 2024 • San Diego, CA